vs

Side-by-side financial comparison of NACCO INDUSTRIES INC (NC) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $66.8M, roughly 1.2× NACCO INDUSTRIES INC). NACCO INDUSTRIES INC runs the higher net margin — -5.8% vs -38.1%, a 32.3% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -5.2%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 11.9%).

NACCO Industries, Inc. is an American publicly traded holding company, headquartered in Cleveland, Ohio. Through a portfolio of mining and natural resources businesses, the company operates under three business segments: Coal Mining, North American Mining, and Minerals Management. The Coal Mining segment operates surface coal mines under long-term contracts with power generation companies and an activated carbon producer pursuant to a service-based business model. The North American Mining se...

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

NC vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.2× larger
PRCT
$83.1M
$66.8M
NC
Growing faster (revenue YoY)
PRCT
PRCT
+25.4% gap
PRCT
20.2%
-5.2%
NC
Higher net margin
NC
NC
32.3% more per $
NC
-5.8%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
11.9%
NC

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
NC
NC
PRCT
PRCT
Revenue
$66.8M
$83.1M
Net Profit
$-3.8M
$-31.6M
Gross Margin
18.0%
64.9%
Operating Margin
11.3%
-4.1%
Net Margin
-5.8%
-38.1%
Revenue YoY
-5.2%
20.2%
Net Profit YoY
-150.8%
-27.9%
EPS (diluted)
$-0.53
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NC
NC
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$66.8M
$76.4M
Q3 25
$76.6M
$83.3M
Q2 25
$68.2M
$79.2M
Q1 25
$65.6M
$69.2M
Q4 24
$70.4M
$68.2M
Q3 24
$61.7M
$58.4M
Q2 24
$52.3M
$53.4M
Net Profit
NC
NC
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-3.8M
$-29.8M
Q3 25
$13.3M
$-21.4M
Q2 25
$3.3M
$-19.6M
Q1 25
$4.9M
$-24.7M
Q4 24
$7.6M
$-18.9M
Q3 24
$15.6M
$-21.0M
Q2 24
$6.0M
$-25.6M
Gross Margin
NC
NC
PRCT
PRCT
Q1 26
64.9%
Q4 25
18.0%
60.6%
Q3 25
13.0%
64.8%
Q2 25
10.0%
65.4%
Q1 25
14.7%
63.9%
Q4 24
12.0%
64.0%
Q3 24
11.7%
63.2%
Q2 24
13.4%
59.0%
Operating Margin
NC
NC
PRCT
PRCT
Q1 26
-4.1%
Q4 25
11.3%
-40.6%
Q3 25
8.8%
-27.8%
Q2 25
-0.1%
-28.0%
Q1 25
11.7%
-39.7%
Q4 24
5.5%
-28.9%
Q3 24
31.9%
-38.4%
Q2 24
14.1%
-50.3%
Net Margin
NC
NC
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-5.8%
-39.1%
Q3 25
17.3%
-25.7%
Q2 25
4.8%
-24.7%
Q1 25
7.5%
-35.8%
Q4 24
10.7%
-27.6%
Q3 24
25.4%
-35.9%
Q2 24
11.4%
-48.0%
EPS (diluted)
NC
NC
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-0.53
$-0.54
Q3 25
$1.78
$-0.38
Q2 25
$0.44
$-0.35
Q1 25
$0.66
$-0.45
Q4 24
$0.99
$-0.34
Q3 24
$2.14
$-0.40
Q2 24
$0.81
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NC
NC
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$49.7M
$245.6M
Total DebtLower is stronger
$100.8M
$51.7M
Stockholders' EquityBook value
$429.2M
$347.7M
Total Assets
$661.2M
$487.1M
Debt / EquityLower = less leverage
0.23×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NC
NC
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$49.7M
$286.5M
Q3 25
$52.7M
$294.3M
Q2 25
$49.4M
$302.7M
Q1 25
$61.9M
$316.2M
Q4 24
$72.8M
$333.7M
Q3 24
$63.1M
$196.8M
Q2 24
$62.4M
$214.1M
Total Debt
NC
NC
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$100.8M
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$99.4M
$51.5M
Q3 24
$51.4M
Q2 24
$29.0M
$51.4M
Stockholders' Equity
NC
NC
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$429.2M
$365.9M
Q3 25
$426.4M
$380.3M
Q2 25
$413.1M
$385.8M
Q1 25
$409.1M
$389.2M
Q4 24
$404.9M
$402.2M
Q3 24
$397.3M
$241.2M
Q2 24
$384.1M
$251.8M
Total Assets
NC
NC
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$661.2M
$508.1M
Q3 25
$637.6M
$511.5M
Q2 25
$631.3M
$513.1M
Q1 25
$634.2M
$519.4M
Q4 24
$631.7M
$534.0M
Q3 24
$597.4M
$374.1M
Q2 24
$560.1M
$374.4M
Debt / Equity
NC
NC
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.23×
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.25×
0.13×
Q3 24
0.21×
Q2 24
0.08×
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NC
NC
PRCT
PRCT
Operating Cash FlowLast quarter
$11.4M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NC
NC
PRCT
PRCT
Q1 26
Q4 25
$11.4M
$-10.3M
Q3 25
$42.3M
$-6.6M
Q2 25
$-7.8M
$-15.0M
Q1 25
$5.0M
$-17.0M
Q4 24
$25.2M
$-32.4M
Q3 24
$2.8M
$-18.8M
Q2 24
$4.1M
$-15.7M
Free Cash Flow
NC
NC
PRCT
PRCT
Q1 26
Q4 25
$-12.2M
Q3 25
$-9.5M
Q2 25
$-17.8M
Q1 25
$-18.8M
Q4 24
$-33.6M
Q3 24
$-19.0M
Q2 24
$-16.8M
FCF Margin
NC
NC
PRCT
PRCT
Q1 26
Q4 25
-15.9%
Q3 25
-11.4%
Q2 25
-22.5%
Q1 25
-27.2%
Q4 24
-49.2%
Q3 24
-32.6%
Q2 24
-31.4%
Capex Intensity
NC
NC
PRCT
PRCT
Q1 26
Q4 25
2.4%
Q3 25
3.4%
Q2 25
3.5%
Q1 25
2.7%
Q4 24
1.7%
Q3 24
0.4%
Q2 24
2.0%
Cash Conversion
NC
NC
PRCT
PRCT
Q1 26
Q4 25
Q3 25
3.19×
Q2 25
-2.39×
Q1 25
1.03×
Q4 24
3.33×
Q3 24
0.18×
Q2 24
0.68×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NC
NC

Transferred Over Time$42.7M64%
Transferred At Point In Time$24.1M36%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons